Kiri

20, AVENUE APPIA – CH-1211 GENEVA 27 – SWITZERLAND – TEL CENTRAL +41 22 791 2111 – FAX CENTRAL +41 22 791 3111 – WWW.WHO.INT Ref.: C.L.46.2021 The Director-General of the World Health Organization has the honour to communicate to Members of the Organization, in accordance with Rules 5 and 8 of the Rules of Procedure of the ... Executive Board, the provisional agenda and provisional annotated agenda for the 150th session of the Executive Board, which will be convened on Monday, 24 January 2022,1 commencing at 10:00 (CET). In light of the current global situation, and following a decision taken by the Executive Board through a written silence procedure, the 150th session of the Executive Board will be held using a hybrid format which involves having the Board members participate in-person, should they wish to do so, and other Member States, as well as other categories of participants participating through a virtual platform. Registration can be initiated as of 10 January 2022 by going to the following link: https://indico.un.org/e/EB150/PBAC35/fp. Details for accessing the virtual platform will be provided following completion of the registration process. In accordance with resolution WHA49.9 (May 1996), and to support the aim of achievement of SDG 5 (Achieve gender equality and empower all women and girls), the Director-General invites Member States to consider that gender balance be applied to their delegations. Documents for the 150th session of the Executive Board can be accessed on the Internet ... through the WHO website (http://www.who.int/gb/) as they become available and practical information for delegates is attached. The Director-General of the World Health Organization takes this opportunity to renew to Members of the Organization the assurance of his highest consideration. GENEVA, 27 December 2021 1 See Executive Board decision EB149(9), 2 June 2021. ... ENCLS.: (3)  REGISTRATION Online registration is required for both the Executive Board, Programme, Budget and administration Committee of the Executive Board and the World Health Assembly. Registration can be initiated as of 10 January 2022 by going to the following link: https://indico.un.org/e/EB150/PBAC35/fp. Before each meeting, an invitation will be sent to Member States indicating a link to access the electronic Registration System (INDICO) in order to register one Focal Point at the Permanent Mission in Geneva, who will be responsible for registering the delegation. Member States without a Permanent Mission in Geneva should designate a Focal Point in the capital. The same process will apply to all categories of invited participants (the United Nations, Observers, Intergovernmental Organizations and non-State actors in official relations with WHO). Once a Focal Point has been entered into the registration system, he/she will receive by email a unique username and password, and the link to access the registration system. The Focal Point will register and submit the names and titles of the delegates and attach a note verbale (credential) containing the composition of the delegation. The WHO Office of Governing Bodies will verify the information received from the Focal Point, which will then be submitted into the registration system to generate the List of Participants and send the log in details to access the virtual meeting. CREDENTIALS The credentials shall be issued by the Head of State, the Head of Government, the Minister for Foreign Affairs, the Minister of Health, or any other appropriate authority, i.e. Permanent Missions and senior government officials, such as Directors-General for Health. A copy of the credentials will have to be uploaded and submitted through the online registration system before the opening of the 150th session of the Executive Board. Credentials should include the following information for each participant: LAST NAME (in capital letters), first name, title, function, institution, city, gender (unless indicated in title). EXECUTIVE BOARD EB150/1 150th session 26 November 2021 Geneva, 24–29 January 2022 Provisional agenda 1. Opening of the session and adoption of the agenda Documents EB150/1, EB150/1 (annotated), EB150/2 and EB150/INF./1 2. Report by the Director-General Document EB150/3 3. Outcome of the Second special session of the World Health Assembly, held to consider developing a WHO convention, agreement or other international instrument on pandemic preparedness and response 4. Report of the regional committees to the Executive Board Document EB150/4 5. Report of the Programme, Budget and Administration Committee of the Executive Board Document EB150/5 6. Post of Director-General 6.1 Nomination of candidates Document EB150/INF./2 6.2 Draft contract Document EB150/6 6.3 Modalities of the second candidates forum1 1 It is proposed that this subitem should be deleted. EB150/1 Pillar 1: One billion more people benefitting from universal health coverage 7. Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases Documents EB150/7 and EB150/7 Add.1 (a) Draft implementation road map 2023–2030 for the global action plan for the prevention and control of noncommunicable diseases 2013–2030 (b) Draft recommendations to strengthen and monitor diabetes responses within national noncommunicable disease programmes, including potential targets (c) Draft global strategy on oral health (d) Draft recommendations on how to strengthen the design and implementation of policies, including those for resilient health systems and health services and infrastructure, to treat people living with noncommunicable diseases and to prevent and control their risk factors in humanitarian emergencies (e) Progress in the implementation of the global strategy to accelerate the elimination of cervical cancer as a public health problem and in the achievement of its associated goals and targets for the period 2020–2030 (f) Progress achieved in the prevention and control of noncommunicable diseases and the promotion of mental health (g) Draft intersectoral global action plan on epilepsy and other neurological disorders in support of universal health coverage (h) Draft action plan (2022–2030) to effectively implement the global strategy to reduce the harmful use of alcohol as a public health priority (i) Draft recommendations for the prevention and management of obesity over the life course, including potential targets (j) Draft workplan for the global coordination mechanism on the prevention and control of noncommunicable diseases 8. The global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections Document EB150/8 9. Global strategy for tuberculosis research and innovation Document EB150/9 2  EB150/1 10. Road map for neglected tropical diseases 2021–2030 Document EB150/10 11. Immunization Agenda 2030 Document EB150/11 12. Infection prevention and control Document EB150/12 13. Global road map on defeating meningitis by 2030 Document EB150/13 14. Standardization of medical devices nomenclature Document EB150/14 Pillar 2: One billion more people better protected from health emergencies 15. Public health emergencies: preparedness and response 15.1 Strengthening WHO preparedness for and response to health emergencies Documents EB150/15 and EB150/16 15.2 Standing Committee on Pandemic and Emergency Preparedness and Response Document EB150/17 15.3 WHO’s work in health emergencies Document EB150/18 15.4 Influenza preparedness Document EB150/19 15.5 Global Health for Peace Initiative Document EB150/20 16. Poliomyelitis 16.1 Poliomyelitis eradication Document EB150/21 3 EB150/1 16.2 Polio transition planning and polio post-certification Document EB150/22 Pillar 3: One billion more people enjoying better health and well-being 17. Maternal, infant and young child nutrition Document EB150/23 18. WHO’s implementation framework for Billion 3 Document EB150/24 • WHO global strategy for food safety Documents EB150/25 and EB150/26 Pillar 4: More effective and efficient WHO providing better support to countries 19. Budget and finance matters 19.1 Financing and implementation of the Programme budget 2020–2021 and outlook on financing of the Programme budget 2022–2023 Document EB150/27 19.2 Programme budget 2022–2023 Documents EB150/28 and EB150/29 19.3 Sustainable financing: report of the Working Group Document EB150/30 19.4 Scale of assessments 2022–2023 Document EB150/31 19.5 Status of collection of assessed contributions, including Member States in arrears in the payment of their contributions to an extent that would justify invoking Article 7 of the Constitution situation in respect of 2020 Document EB150/32 19.6 Amendments to the Financial Regulations and Financial Rules [if any] 4  EB150/1 20. Management matters 20.1 Prevention of sexual exploitation, abuse and harassment Documents EB150/33 and EB150/34 20.2 Evaluation: update and proposed workplan for 2022–2023 Document EB150/35 21. Governance matters 21.1 Global strategies and plans of action that are scheduled to expire within one year • Global strategy and plan of action on public health, innovation and intellectual property Document EB150/36 21.2 WHO reform: involvement of non-State actors in WHO’s governing bodies Document EB150/37 21.3 Engagement with non-State actors • Report on the implementation of the Framework of Engagement with Non-State Actors Document EB150/38 • Non-State actors in official relations with WHO Document EB150/39 21.4 Provisional agenda of the Seventy-fifth World Health Assembly and date and place of the 151st session of the Executive Board Documents EB150/40 and EB150/41 22. Committees of the Executive Board 22.1 Participation in the Programme, Budget and Administration Committee of the Executive Board Document EB150/42 5 EB150/1 22.2 Independent Expert Oversight Advisory Committee • Terms of reference Document EB150/43 • Membership [if any] 22.3 Foundation committees and selection panels Document EB150/44 23. Staffing matters 23.1 Statement by the representative of the WHO staff associations Document EB150/INF./3 23.2 Report of the Ombudsman Document EB150/INF./4 23.3 Human resources: update Document EB150/45 23.4 Amendments to the Staff Regulations and Staff Rules Document EB150/46 23.5 Report of the International Civil Service Commission Document EB150/47 24. Report on meetings of expert committees and study groups • Expert advisory panels and committees and their membership Documents EB150/48 and EB150/48 Add.1 25. Closure of the session = = = 6 EXECUTIVE BOARD EB150/1 (annotated) 150th session 27 December 2021 Geneva, 24–29 January 2022 Provisional agenda (annotated) 1. Opening of the session and adoption of the agenda During the opening of the session, Members of the Executive Board will be invited to also consider the adoption of special procedures to regulate the conduct of the Executive Board in a hybrid format. 2. Report by the Director-General 3. Outcome of the Second special session of the World Health Assembly, held to consider developing a WHO convention, agreement or other international instrument on pandemic preparedness and response The Board will discuss the outcome of the special session of the World Health Assembly in November 2021, convened pursuant to decision WHA74(16) (2021). 4. Report of the regional committees to the Executive Board The Board will be invited to consider the recommendations and comments of the regional committees in the reports submitted pursuant to decision WHA65(9) (2012). 5. Report of the Programme, Budget and Administration Committee of the Executive Board The Board will receive at the opening of its session the report of the thirty-fifth meeting of the Programme, Budget and Administration Committee, which is scheduled to be held from 19 to 21 January 2022. 6. Post of Director-General 6.1 Nomination of candidates 6.2 Draft contract 6.3 Modalities of the second candidates forum1 1 It is proposed that this subitem should be deleted. EB150/1 (annotated) Pillar 1: One billion more people benefiting from universal health coverage 7. Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases A report will be submitted in response to decisions WHA72(11) (2019), EB146(14) (2020), EB148(3) (2021), WHA74(10) (2021) and WHA74(11) (2021), as well as resolutions WHA73.10 (2020), WHA74.4 (2021) and WHA74.5 (2021), through which the Director-General was requested to develop eight specific assignments on the prevention and control of noncommunicable diseases and the promotion of mental health, and to submit two progress reports. The consolidated report is submitted with 10 Annexes pursuant to decision WHA72(11) with its request for consolidated reporting on prevention and control of noncommunicable diseases and the promotion of mental health. The Board will be invited to note Annexes 5 and 61 and to consider a draft decision recommending the submission of the draft policy instruments contained in Annexes 1, 2, 3, 4, 7, 8, 9 and 10 2 to the Seventy-fifth World Health Assembly for its adoption. 8. The global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections In response to the request in decision WHA74(20) (2021), the Director-General will submit a report outlining draft global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections, for the period 2022–2030. The report will set forth the purpose, vision, goals, strategic directions and the framework for action and implementation of the strategies, which have been developed through a broad consultative process. The Board will be invited to consider the draft strategies and recommend their adoption to the Seventy-fifth World Health Assembly. 9. Global strategy for tuberculosis research and innovation A report will be submitted in response to resolution WHA73.3 (2020), in which the Health Assembly requested the Director-General to report on progress in respect of the End TB Strategy, including implementation of the global strategy for tuberculosis research and innovation in order to inform preparations for the comprehensive review by Heads of State and Government at a United Nations high-level meeting on tuberculosis in 2023. The Board will be invited to note the report and provide further guidance as set out in the document. 10. Road map for neglected tropical diseases 2021–2030 In response to the request made in decision WHA73(33) (2020), the Director-General will submit a report on progress in implementing the road map for neglected tropical diseases 2021–2030. The Board will be invited to note the report and provide guidance on sustaining resources to implement the road map and ensuring that interventions against neglected tropical diseases are considered as part of essential health services in the context of the coronavirus disease (COVID-19) pandemic. 11. Immunization Agenda 2030 1 Dealing with, respectively: elimination of cervical cancer; and prevention and control of noncommunicable diseases and promotion of mental health. 2 Dealing with, respectively: the draft implementation roadmap 2023–2030 for the global action plan for the prevention and control of noncommunicable diseases 2013–2030; the draft recommendations to strengthen diabetes responses; the draft global strategy on oral health; the draft recommendations on policies for the prevention and control of noncommunicable diseases in humanitarian emergencies; the draft intersectoral global action plan on epilepsy and other neurological disorders; the draft action plan for implementing the global strategy to reduce the harmful use of alcohol; the draft recommendations for the prevention of obesity; and the draft workplan for the global coordination mechanism on the prevention and control of noncommunicable diseases. 2  EB150/1 (annotated) In line with resolution WHA70.14 (2017) and decision WHA73(9) (2020), the Director-General will submit a report on progress made towards achieving the goals of the Immunization Agenda 2030, including a summary of the draft global report for 2021 on the Immunization Agenda 2030, which provides baseline data to track progress in immunization up to 2030 and details the implementation status at country, regional and global levels. The Board will be invited to note the report and provide guidance as set out in the document. 12. Infection prevention and control The Director-General will submit a report on the spread of infection and antimicrobial resistance in health care facilities and its impact, and on the global situation of programmes for infection prevention and control at the national and facility levels, including gaps and challenges. The report will also provide an overview of WHO’s recent activities on infection prevention and control and will propose some priorities and actions aimed at improving associated programmes. The Board will be invited to note the report and provide further guidance. 13. Global road map on defeating meningitis by 2030 Pursuant to resolution WHA73.9 (2020) the Director-General will submit a progress report on the Global road map on defeating meningitis by 2030. The Board will be invited to note the report and provide further guidance, in particular on establishing a strategic support group to raise the profile of meningitis and to advise on how to strengthen the integration of meningitis prevention and management in primary health care. 14. Standardization of medical devices nomenclature During discussions at the Seventy-fourth World Health Assembly in May 2021, Member States recognized the need for a standardized medical devices nomenclature and called for further activities, consultations and information sessions to be organized on the subject. The Secretariat gave an undertaking to submit a new report on the matter to the Executive Board at its 150th session. The report by the Director-General includes details on the Secretariat’s response to Member States’ requests and on the outcome of surveys and consultations completed. The Board will be invited to note the report and consider a draft decision. Pillar 2: One billion more people better protected from health emergencies 15. Public health emergencies: preparedness and response 15.1 Strengthening WHO preparedness for and response to health emergencies Pursuant to resolution WHA74.7 (2021) the Director-General will present a report on implementation of the resolution, including support provided to the Working Group on Strengthening WHO Preparedness and Response to Health Emergencies. The Board will be invited to note the report and provide further guidance. Pursuant to resolution WHA74.7 (2021), paragraph 6, the Director-General will transmit to the Board the report of the Member States Working Group on Strengthening WHO Preparedness and Response to Health Emergencies with proposed actions for the Member States, WHO Secretariat, and non-State actors, as appropriate, for consideration by the Seventy-fifth World Health Assembly. The Board will be invited to note the report and provide further guidance. 15.2 Standing Committee on Pandemic and Emergency Preparedness and Response At the recommendation of the Officers of the Executive Board in 2021, the Director-General will transmit a report with a proposal for the creation of a Standing Committee on Pandemic and Emergency Preparedness and Response 3 EB150/1 (annotated) to provide guidance and, as appropriate, make recommendations to the Board regarding ongoing work on policy proposals on pandemic and emergency preparedness and response. 15.3 WHO’s work in health emergencies Pursuant to requests in resolution EBSS3.R1 (2015), decision WHA68(10) (2015) and resolution WHA73.8 (2020), the Director-General will submit a report that provides information on all WHO Grade 3 emergencies, the United Nations Inter-Agency Standing Committee Level 3 emergencies, and public health emergencies of international concern that required a response by WHO in 2021 (up to 30 September) at global, regional and country levels in order to prepare for, prevent, detect and respond to health emergencies. It will also describe the response to the request in resolution WHA73.8 in respect of the Surveillance System for Attacks on Health Care in complex humanitarian emergencies. The Board will be invited to note the report. 15.4 Influenza preparedness In response to the request in decision WHA73(14) (2020), the Director-General will submit a report on progress made in implementing that decision, including implementing the Global Influenza Strategy 2019–2030, enhancing surveillance through the Global Influenza Surveillance and Response System, and promoting and upholding the Pandemic Influenza Preparedness Framework. The Board will be invited to note the report and provide guidance as set out in the document. 15.5 Global Health for Peace Initiative At the recommendation of the Officers of the Executive Board in 2021,1 the Director-General will submit a report on the Global Health for Peace Initiative, which seeks to position the health sector as a contributor to peace and social cohesion by mainstreaming conflict sensitivity and peace responsiveness into WHO’s programmes. The report will outline the work of the Initiative, its achievements and the proposed ways forward. The Board will be invited to take note of the report and to provide guidance as set out in the document. 16. Poliomyelitis 16.1 Poliomyelitis eradication In line with current mandates, including resolution WHA71.15 (2018), the Director-General will submit a report providing an update on work towards Goals 1 and 2 of the Polio Eradication Strategy 2022–2026 (which received support at the Seventy-fourth World Health Assembly), notably on: interrupting all poliovirus transmission in countries where the virus is endemic, and stopping transmission of circulating vaccine-derived poliovirus and preventing outbreaks in non-endemic countries; the ongoing impact of the COVID-19 pandemic on the global polio eradication effort; and, the current financing situation at the end of 2021. The Board will be invited to note the report. 16.2 Polio transition planning and polio post-certification Pursuant to decision WHA70(9) (2017), the Director-General will provide a status update on the implementation of WHO’s Strategic Action Plan on Polio Transition for the period 2019–2023, with a focus on progress and challenges at the country level. The Board will be invited to note the report and provide guidance as set out in the document. 1 See Note at end of document. 4  EB150/1 (annotated) Pillar 3: One billion more people enjoying better health and well-being 17. Maternal, infant and young child nutrition Following the request in decision WHA73(26) (2020), the Director-General will submit a report on maternal, infant and young child nutrition, including the biennial report on the progress in implementing the International Code of Marketing of Breast-milk Substitutes and guidance on ending the inappropriate promotion of foods for infants and young children. The report will also include as an annex a report on the scope and impact of digital marketing strategies for the promotion of breast-milk substitutes. The Board will be invited to note the report and its annex and to consider a draft decision that will recommend that the Seventy-fifth World Health Assembly request guidance for Member States on regulatory measures aimed at restricting the digital marketing of breast-milk substitutes. 18. WHO’s implementation framework for Billion 3 The Secretariat’s Implementation Framework for the strategic priority of healthier populations guides the work across the three levels of WHO to achieve the goal of one billion more people enjoying better health and well-being. The Director-General will submit a report that describes how the framework is put into operation through 10 flagship initiatives that reflect the cross-cutting and multisectoral approach towards that goal. The Board will be invited to note the report and provide further guidance as set out in the document. • WHO global strategy for food safety In response to the request in resolution WHA73.5 (2020), the Director-General will submit a report on the update of the WHO global strategy for food safety, outlining the updating process and summarizing the main content of the draft strategy. The Board will be invited to consider a draft decision that will recommend that the Seventy-fifth World Health Assembly, inter alia, adopt the updated global strategy. • Reducing public health risks associated with the sale of live wild animals of mammalian species in traditional food markets – infection prevention and control Following the recommendation of the Officers of the Board in September 2021,1 the Director-General will submit a report that summarizes the measures recommended by WHO, OIE and UNEP on reducing public health risks associated with the sale of live wild animals of mammalian species in traditional food markets and describes its planned work, linked with the implementation of the food safety strategy and to the One Health initiative. The Board is invited to note the report. Pillar 4: More effective and efficient WHO providing better support to countries 19. Budget and finance matters 19.1 Financing and implementation of the Programme budget 2020–2021 and outlook on financing of the Programme budget 2022–2023 The Director-General will submit a report on the financing and implementation of the Programme budget 2020–2021 and provide an update on the financial situation for the Programme budget 2022–2023. The Board will be invited to note the report. 19.2 Programme budget 2022–2023 1 See Note at end of document. 5 EB150/1 (annotated) In response to a request in resolution WHA74.3 (2021) the Director-General will submit an outline of a proposed revision of the Programme budget 2022–2023. The Director-General will also submit a report setting forth the rationale for extending the period of the Thirteenth General Programme of Work. The proposed extension is the response to the fact that global efforts to meet the triple billion targets and the Sustainable Development Goals are off track, with the COVID-19 pandemic exacerbating the difficulties faced. The Board will be invited to consider a draft resolution recommending that the Seventy-fifth World Health Assembly approve the extension of the end date of the Thirteenth General Programme of Work until 2025. 19.3 Sustainable financing: report of the Working Group Pursuant to decision EB148(12) (2021) and reflecting comments made during the discussions at the thirty-third meeting of the Programme, Budget and Administration Committee of the Executive Board (October 2020) and in Committee B of the Seventy-third World Health Assembly (resumed, November 2020), the Director-General will transmit the final report of the Working Group on Sustainable Financing with its recommendations and other findings for consideration by the Board. 19.4 Scale of assessments 2022–2023 The Director-General will submit the report on the revised scale of assessments for the financial period 2022–2023, together with a draft resolution recommending adoption of the scale by the Seventy-fifth World Health Assembly. 19.5 Status of collection of assessed contributions, including Member States in arrears in the payment of their contributions to an extent that would justify invoking Article 7 of the Constitution: situation in respect of 2020 The Director-General will submit a report on status of collection of assessed contributions, including Member States in arrears in the payment of their contributions to an extent that would justify invoking Article 7 of the Constitution, together with a draft resolution recommending adoption of a resolution by the Seventy-fifth World Health Assembly in respect of Member States in arrears in the payment of their contributions. 19.6 Amendments to the Financial Regulations and Financial Rules [if any] 20. Management matters 20.1 Prevention of sexual exploitation, abuse and harassment The Director-General will submit a report pursuant to decision EB148(4) (2021), together with an update on implementation of WHO’s management response plan in respect of the report of the Independent Commission on Allegations of Sexual Exploitation and Abuse during the Response to the 10th Ebola Outbreak in the Democratic Republic of the Congo. The Board will be invited to note the report. The Director-General will also transmit to the Board the report of the Independent Oversight and Advisory Committee for the WHO Health Emergencies Programme, containing the findings and recommendations of its subcommittee on sexual exploitation, abuse and harassment. The report covers ways of strengthening WHO’s policies and procedures in this area, including the following: clarifying staff roles, responsibilities and reporting lines; building capacity, coherence, and expertise internally; implementing a risk-based approach; and leading a transformative change in culture. The Board will be invited to note consider the report. 6  EB150/1 (annotated) 20.2 Evaluation: update and proposed workplan for 2022–2023 The Evaluation Office will submit a report that describes progress in implementing the evaluation workplan for 2020–2021 and sets out the proposed evaluation workplan for 2022–2023. The latter incorporates both the corporate and decentralized evaluations planned and developed through consultation at senior management level across the Organization and discussed with the Independent Expert Oversight Advisory Committee. The Board will be invited to note the report and approve the proposed workplan. 21. Governance matters 21.1 Global strategies and plans of action that are scheduled to expire within one year • Global strategy and plan of action on public health, innovation and intellectual property As requested in decision WHA73(15) (2020) on WHO reform: governance, regarding global strategies or action plans that are scheduled to expire within one year, the Director-General will submit a report on the implementation of the global strategy and plan of action on public health, innovation and intellectual property. The Board will be invited to note the report and provide further guidance as set out in the document. 21.2 WHO reform: involvement of non-State actors in WHO’s governing bodies As requested by the Board in February 2021 at its 148th session, the Secretariat trialed virtual informal meetings with non-State actors in official relations, Member States and the Secretariat ahead of the Seventy-fourth World Health Assembly. It also trialed constituency statements for a limited number of agenda items at the Health Assembly. The Director-General will submit a report to the Board on the feedback received on the trials and proposals for the way forward. The Board will be invited to note the report and consider a draft decision proposing continuation of the informal meetings annually before sessions of the Health Assembly, and for trialing constituency statements again during the Seventy-fifth World Health Assembly. 21.3 Engagement with non-State actors • Report on the implementation of the Framework of Engagement with Non-State Actors In accordance with resolution WHA69.10 (2016) and the Framework of Engagement with Non-State Actors (subparagraph 68(a)), the Director-General will submit the sixth annual report on WHO’s implementation of the Framework, illustrating engagements with entities and reporting on the different aspects of the implementation of the Framework at the three levels of the Organization. The Board will be invited to note the report. • Non-State actors in official relations with WHO In line with the provisions of the Framework of Engagement with Non-State Actors, the Executive Board is mandated, through its Programme, Budget and Administration Committee, to consider applications for admittance of non-State actors into official relations and to review collaboration with one third of the non-State actors in official relations in order to decide whether to maintain, defer the review or discontinue their official relations. The Board will be invited to note the report and to consider a draft decision. 21.4 Provisional agenda of the Seventy-fifth World Health Assembly and date and place of the 151st session of the Executive Board 22. Committees of the Executive Board 22.1 Participation in the Programme, Budget and Administration Committee of the Executive Board 7 EB150/1 (annotated) The Board will be invited to consider a report on the implementation of decision EB146(5) (2020), through which the Board amended the terms of reference of the Programme, Budget and Administration Committee so as to allow a set of observers to attend its meetings in certain conditions. The Board will be invited to note the report and provide further guidance as set out in the document. 22.2 Independent Expert Oversight Advisory Committee • Terms of reference The Director-General will transmit for the Board’s consideration a report presenting proposed revisions to the Advisory Committee’s Terms of reference. • Membership [if any] 22.3 Foundation committees and selection panels The Director-General will submit reports summarizing the outcomes of the meetings of the selection panels for the prizes to be awarded in 2022. 23. Staffing matters 23.1 Statement by the representative of the WHO staff associations In a statement to the Board, the representative of the staff associations of WHO, IARC, PAHO and UNAIDS will highlight the views of the members on issues currently seen as of great importance for the Organization. 23.2 Report of the Ombudsman Since 2018, all ombudsmen across WHO have issued a combined annual report of their activities to the Board. The Ombudsman will present a report drafted after consultation with regional ombudsmen that describes their activities since the previous report. The report will also outline the most relevant systemic issues identified during that period and the follow-up on the administration’s response to the recommendations made in previous reports. 23.3 Human resources: update The Director-General will submit an update to the human resources annual report for 2020 noted by the Seventy-fourth World Health Assembly in May 2021. The report will summarize workforce data and describe activities conducted under the human resources strategy and within the major transformation workstreams. The Board will be invited to note the report. 23.4 Amendments to the Staff Regulations and Staff Rules Amendments to the Staff Rules made by the Director-General will be submitted for confirmation by the Board in accordance with Staff Regulation 12.2. Proposed amendments to the Staff Regulations will be submitted for the Board to consider their submission to the Seventy-fifth World Health Assembly. The Board will be invited to note the report and consider three draft resolutions. 23.5 Report of the International Civil Service Commission The Director-General will transmit the Commission’s report and recommendations to the Board. The Secretariat will provide the Board with a verbal summary of the salient points. The Board will be invited to note the report. 8  EB150/1 (annotated) 24. Report on meetings of expert committees and study groups • Expert advisory panels and committees and their membership In compliance with Regulation 4.23 of the Regulations for Expert Advisory Panels and Committees, the Director-General will submit a report on meetings of expert committees and study groups, including a summary of the recommendations contained in the reports of expert committees and observations on their significance for public health policies and implications for the Organization’s programmes. The Board will be invited to note the report. In addition, the Director-General will provide details of both meetings and membership in respect of expert committees that met in 2021. 25. Closure of the session Note:1 The Officers of the Executive Board met with the Director-General on 30 September 2021. The meeting was organized using a hybrid format, with some participants physically present in Geneva and others attending virtually by means of video conference technology. Dr Wahid Majrooh (Afghanistan) Vice-Chair was unable to attend. PURPOSE OF THE MEETING 1. In accordance with Rule 8 of the Rules of Procedure of the Executive Board, the meeting would review the existing draft provisional agenda of the 150th session of the Board, to be held in January 2022, in order to prepare the Provisional agenda. In addition, the Officers would discuss possible modalities for the forthcoming meetings of the governing bodies, namely: the second special session of the World Health Assembly, the 150th session of the Executive Board and the thirty-fifth meeting of the Programme, Budget and Administration Committee of the Executive Board. 2. Welcoming the Officers and other attendees, the Director-General expressed his satisfaction at being able to meet the Chair of the Executive Board and other Officers in person. It was to be hoped that the positive trend would continue. 3. The meeting was chaired by the Chair of the Executive Board. In his opening comments, the Chair welcomed the Officers, noting that the Regional Coordinators had been invited to attend as observers. 4. The Officers agreed to the proposed method of work. At the proposal of the Chair of the Executive Board, they also agreed to discuss together the items on (i) the prioritization of proposals for the provisional agenda and (ii) the preparation of that agenda. PROVISIONAL AGENDA OF THE 150TH SESSION OF THE EXECUTIVE BOARD Existing subitem proposed for deletion 5. In line with the Chair’s proposal, the Officers of the Executive Board first considered the proposal made by the Government of Oman to delete the bullet point under item 15.2 of the draft provisional agenda, contained 1 See the Note for the Record of the meeting of the Director-General with the Officers of the Executive Board on 30 September 2021 (https://apps.who.int/gb/gov/en/chair-and-officers-of-the-executive-board_en.html). 9 EB150/1 (annotated) in the section under Pillar 2 (One billion more people better protected from health emergencies). The item, entitled “The Coalition for Universal Health Protection Architecture Initiative”, had originally been proposed by the Member State for inclusion on the agenda of the Executive Board at its 149th session in May 2021. In their deliberations at the time, the Officers had recommended that consideration of the item should be deferred to the Board’s 150th session. However, the Government of Oman’s view was that the subject did not, in fact, require discussion at the current time. The Officers decided to recommend that the item should be removed from the provisional agenda. New items proposed by the Member States 6. The Chair informed the Officers that 10 proposals for new agenda items had been received by the deadline of 22 September. 7. The Chair reminded Officers of the template, requested by the Executive Board at its 144th session, which invited Officers to bear in mind two further criteria when considering proposed additional items, namely: whether the items covered an urgent topic or involved a subject that was time-sensitive and that had not been considered recently by the governing bodies. The template further suggested that Officers should consider: the last time the proposed item was considered by the governing bodies; any work performed currently by WHO in relation to the proposed item; and the existence of reporting requirements in relation to the proposed item. 8. The Chair proposed that, following their review, the Officers should decide between five options: Option 1: accept the proposal as a new agenda item Option 2: combine the proposed item with an existing item Option 3: defer the proposed item to a later session Option 4: refer the proposal to another governing body, such as the regional committees or the Programme, Budget and Administration Committee of the Executive Board Option 5: exclude the proposal. 9. The Chair also drew the Officers’ attention, in their consideration of the proposals, to the points set out below. • The 150th session of the Executive Board, to be held over six working days was already scheduled to deal with 25 items, more per day that at the Board’s 148th session, held over eight days, which had considered 23 items. If all the proposed additional items were accepted, the Board would be considering 35 items in January 2022. • Certain matters already due to be covered in the draft Provisional agenda of the 150th session of the Executive Board would inevitably involve lengthy discussions, namely: the report of the Working Group on Sustainable Financing, the Programme budget 2022–2023 and the election of the Director-General. • It was important to ensure that the attention given to the various pillars of the Thirteenth General Programme of Work, 2019–2023 was balanced. 10. Mindful in their decision-making of the importance of allowing nothing to distract the Organization from its focus on ending the pandemic of coronavirus disease (COVID-19), the Officers of the Board agreed to make the recommendations set forth below: 10  EB150/1 (annotated) Pillar 1: One billion more people benefiting from universal health coverage • that the item proposed by the Government of Spain on transplantation in the continuum of care of noncommunicable diseases should be excluded, having heard from the Secretariat that the matter was already due to be discussed at the Seventy-fifth World Health Assembly in 2022; • that the item proposed by the Governments of Colombia, Israel, Kenya and Rwanda on “Strengthening Rehabilitation in Health Systems” should be deferred to a future meeting;1 Pillar 2: One billion more people better protected from health emergencies • that the item proposed by the Government of Austria, entitled “Standing Committee on Pandemic and Emergency Preparedness and Response (SCPPR)”, should be combined with existing item 3 on the provisional agenda of the 150th session of the Executive Board, becoming a new second subitem under that item, which itself should be renamed “Strengthening WHO”; that the original item title “Outcome of the special session of the World Health Assembly to consider developing a WHO convention, agreement or other international instrument on pandemic preparedness and response” should be used to create a new subitem 3.1; and that the Secretariat should decide whether the item was best placed under Pillar 2 or Pillar 4; • that the item proposed by the Government of Colombia on the implementation of smart vaccination certificates in the context of the COVID-19 pandemic and international travel worldwide should be excluded, with the Officers noting that the Secretariat was already undertaking work on the matter and that differences between Member States in levels of access to vaccines meant that the initiative was premature; Pillar 3: One billion more people enjoying better health and well-being • that the item proposed by the Government of Sri Lanka entitled “Rapid phase-out of all highly hazardous pesticides from agricultural use by 2030, in line with the SDGs” should be referred for review by the regional committees1 as there was agreement among the Officers that the issue, although important, was of regional rather than global public health significance; • that the item proposed by the Government of the United Arab Emirates on well-being should be excluded, with the Officers commenting that the proponents might wish to consider revising the proposal to make it more specific before resubmitting it for a future meeting, taking into account also the outcomes of the 10th Global Conference on Health Promotion due to be held in December 2021; • that the item proposed by the Government of Fiji on the outcomes of the first Small Island Developing States (SIDS) Summit for Health should be deferred to the 152nd session of the Executive Board in January 2023, with the Officers noting that, notwithstanding its growing urgency, the subject had already been discussed at the Seventy-fourth World Health Assembly in May 2021, and that the recommendations of the Summit for Health could be reported to the Executive Board at its 152nd session; • that the item proposed by the Government of the Netherlands, entitled “Reducing public health risks associated with the sale of live wild animals of mammalian species in traditional food markets – Infection Prevention and Control”, should be dealt with under the existing item on food safety on the provisional agenda of the 150th session of the Executive Board; 1 The Secretariat will provide information on a specific meeting in due course. 11 EB150/1 (annotated) Pillar 4: More effective and efficient WHO providing better support to countries • that the item proposed by the Government of Nigeria, entitled “World Cervical Cancer Elimination Day”, should be excluded, with the Director-General suggesting that the time had come to consider taking a comprehensive approach to such proposals, rather than dealing with them in a piecemeal manner; • that the item proposed by the Government of Bahrain, entitled “Global Health Diplomacy Framework: to advance the integration of health in all policies”, could rather be integrated into the curriculum of the recently inaugurated WHO Academy and work on the outcome of the 10th Global Conference on Health Promotion, as the proposal was essentially academic in nature. 11. Two further additional items – on the implementation of the community care model in mental health in times of COVID-19 and the development of an emergency rapid response team – proposed, respectively, by the Governments of Peru and Iraq, were not considered by the Officers as they had been received after the deadline of 22 September. = = = 12 Saatja: <[email protected]> Saadetud: 27.12.2021 17:35 Teema: WHO: C.L.46.2021 - EB150 Dear Member States of the World Health Organization,Please find attached, in the six official languages, C.L.46.2021 regarding the 150th session of the Executive Board (24-29 January 2022).Best regards,Department of Governing BodiesWorld Health Organization